News

BranchOut Food Inc. Expands Market Reach with Major Agreement

BranchOut Food Inc. Expands Market Reach with Major Agreement

BranchOut Food Inc. Expands Market Reach with Major Agreement

Key Highlights:

Signed LOI with leading ingredient distributor, establishing immediate sales in the ingredient channel.

Initial purchase order valued at $250,000 issued alongside the LOI.

Definitive Agreement expected to finalize soon with a commitment of at least $5 million in sales for 2025.

New production lines in Peru are fully operational, poised to disrupt a $36 billion market.

BranchOut Food Inc. (NASDAQ: BOF), renowned for its innovative GentleDry™ dehydration technology, has recently signed a Letter of Intent (LOI) with a prominent distributor focused on dried food ingredients. This represents a significant advancement in BranchOut’s strategy to expand its market footprint and meet the rising demand for high-quality ingredients.

As part of this LOI, the distributor has placed an initial purchase order worth approximately $250,000. This order signals strong initial sales momentum and sets the foundation for a definitive agreement expected to be completed in the near future. This agreement will position BranchOut as the exclusive supplier for several products, leveraging the advantages of GentleDry™ technology and the benefits of its advanced production facility in Peru.

A Transformative Partnership for Growth

BranchOut Food’s collaboration with this experienced distributor marks a critical moment in its three-channel sales strategy. This partnership builds on significant growth in their branded and private label retail operations, which have already made strides into some of the largest retail chains. This agreement allows for immediate entry into the ingredient market without the need for additional sales or marketing expenditures.

"This partnership accelerates our ability to capture growth in the ingredient channel while allowing us to focus resources on scaling our branded and private label retail channels," stated Eric Healy, CEO of BranchOut Food. "It reinforces our strong revenue growth as we head into the coming years."

Innovative Production Capabilities Fueling Expansion

With its facility in Peru now fully operational and featuring the largest GentleDry™ production capacity in the world, BranchOut is strategically positioned to increase production efficiency and bolster profitability. This innovative technology not only enhances the quality of food but also preserves essential nutrients, setting BranchOut apart in a competitive industry.

The Brazilian freeze-dried market alone, valued at more than $36 billion and projected to grow annually, faces challenges with rising costs due to tariffs and import issues. However, BranchOut Food is distinguishing itself with its GentleDry™ technology, which is touted for being more efficient and offering better quality at lower costs.

“We believe our GentleDry™ technology outperforms traditional freeze-drying methods, both in efficiency and cost-effectiveness,” said Eric Healy. “This partnership is a pivotal step in launching our products in the ingredient market and challenging the freeze-dried sector's status quo.”

BranchOut Food Inc. - A Leader in Dehydration Technology

As a major player in the food technology industry, BranchOut Food specializes in creating high-quality dehydrated products from fruits and vegetables using its proprietary GentleDry™ Technology. This advanced method retains up to 95% of the original nutrients, allowing BranchOut to offer products that stand out in terms of flavor and quality.

Thanks to its robust patent portfolio with over 17 patents, BranchOut Food has established itself as a trusted brand and supplier in both retail and private label segments. The company's commitment to innovation and quality continues to drive its success and expansion in both local and international markets.

Frequently Asked Questions

What is the recent development for BranchOut Food Inc.?

BranchOut Food Inc. has signed a Letter of Intent with a leading ingredient distributor and received a $250,000 purchase order.

What is the expected sales target for 2025?

The partnership aims for anticipated sales of $5 million to $6 million in 2025.

How does BranchOut Food's technology differ from traditional methods?

BranchOut's GentleDry™ technology preserves more nutrients and offers superior quality compared to traditional freeze-drying methods.

Where is BranchOut Food's production facility located?

BranchOut Food operates a state-of-the-art facility in Peru that is now fully operational.

Who is the CEO of BranchOut Food Inc.?

Eric Healy serves as the CEO of BranchOut Food Inc.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading